Daniela Geiger, Vetter10.04.19
There is a good deal of talk in the pharmaceutical industry about serialization, and for good reason. Serialization combined with the system of track-and-trace constitutes the industries vigorous response to the growing problem of drug counterfeiting. Purposely producing and selling a drug that is intended to deceive, i.e. drug counterfeiting, is costing the industry tens of millions of dollars annually. Just as important, drug counterfeiting is a dangerous act and imperils the lives of those the industry works hardest to protect—the patients that must rely on safe and effective medications.
Easy to define, hard to combat
Drug counterfeiting is easy to define. Quite simply, it is a pharmaceutical product that is produced and sold with the deliberate intent of deceptively representing its origin, authenticity or effectiveness. It may contain incorrect quantities and qualities of active ingredients, or none at all. What is difficult to qualify or quantify, however, is the adverse effect drug counterfeiting has on global health and the cost to the global economy. Estimates of its impact on the industry range anywhere
Easy to define, hard to combat
Drug counterfeiting is easy to define. Quite simply, it is a pharmaceutical product that is produced and sold with the deliberate intent of deceptively representing its origin, authenticity or effectiveness. It may contain incorrect quantities and qualities of active ingredients, or none at all. What is difficult to qualify or quantify, however, is the adverse effect drug counterfeiting has on global health and the cost to the global economy. Estimates of its impact on the industry range anywhere
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
